The comprehensive evaluation of STEMI patients by CMR imaging has the potential to provide incremental prognostic information for risk stratification beyond established clinical risk markers. In light of the lack of trials, however, designed to prospectively test the value of a CMR-guided therapeutic strategy in patients with STEMI, the use of CMR for risk stratification of the postinfarction patient awaits further validation and research.